The LUVEN screening test method created by the scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy and none of the existing diagnostic techniques has such a high diagnostic accuracy.
January 15th, 2018
February 28th, 2018
The LUVEN technology allows to diagnose the disease at its early stages, thus, giving a chance to thousands of people to prevent its further development.
For more than 20 years the Ukrainian scientists have been developing a diagnostic method based on cyto-morphological and cyto-biophysical properties of the buccal epithelial cells. In 2004 at Fenix Cancer Research Center, they continued their research and, finally, came up and implemented an experimental method.
A new method of biomaterial analysis allowed to establish a cancer diagnosis at its early stages and to assess predisposition to cancer .A great success in this medical field opened a door to new possibilities, including cancer prevention and therapy.
The longstanding scientific research in this field culminated in development of The Luven diagnostic system.
Postgraduate Student of Chair for Biomedical Engineering
Geneticist & Cytologist
Principal Software Engineer